Recombinant multi-species androgen receptor/AR protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine androgen receptor/AR protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy's disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017]
The Alternative Names of target: AIS,AR,AR8,Andr,Androgen receptor,Ar,DHTR,Dihydrotestosterone receptor,HUMARA,HYSP1,KD,NR3C4,Nuclear receptor subfamily 3 group C member 4,SBMA,SMAX1,TFM,Tfm,androgen receptor
Go
to androgen receptor/AR products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T11211-Ag-1/ GM-Tg-hg-T11211-Ag-2 | Human androgen receptor/AR protein | Human |
GM-Tg-rg-T11211-Ag-1/ GM-Tg-rg-T11211-Ag-2 | Rat androgen receptor/AR protein | Rat |
GM-Tg-mg-T11211-Ag-1/ GM-Tg-mg-T11211-Ag-2 | Mouse androgen receptor/AR protein | Mouse |
GM-Tg-cynog-T11211-Ag-1/ GM-Tg-cynog-T11211-Ag-2 | Cynomolgus/Rhesus macaque androgen receptor/AR protein | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T11211-Ag-1/ GM-Tg-felg-T11211-Ag-2 | Feline androgen receptor/AR protein | Feline |
GM-Tg-cang-T11211-Ag-1/ GM-Tg-cang-T11211-Ag-2 | Canine androgen receptor/AR protein | Canine |
GM-Tg-bovg-T11211-Ag-1/ GM-Tg-bovg-T11211-Ag-2 | Bovine androgen receptor/AR protein | Bovine |
GM-Tg-equg-T11211-Ag-1/ GM-Tg-equg-T11211-Ag-2 | Equine androgen receptor/AR protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-T11211-Ag-1/ GM-Tg-hg-T11211-Ag-2;
GM-Tg-rg-T11211-Ag-1/ GM-Tg-rg-T11211-Ag-2;
GM-Tg-mg-T11211-Ag-1/ GM-Tg-mg-T11211-Ag-2; GM-Tg-cynog-T11211-Ag-1/ GM-Tg-cynog-T11211-Ag-2; GM-Tg-felg-T11211-Ag-1/ GM-Tg-felg-T11211-Ag-2; GM-Tg-cang-T11211-Ag-1/ GM-Tg-cang-T11211-Ag-2; GM-Tg-bovg-T11211-Ag-1/ GM-Tg-bovg-T11211-Ag-2; GM-Tg-equg-T11211-Ag-1/ GM-Tg-equg-T11211-Ag-2 |
Products Name | androgen receptor/AR protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | androgen receptor/AR |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine androgen receptor/AR protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.